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Keratosis follicularis spinulosa decalvans (KFSD) is a rare cornification disorder with
an X-linked recessive inheritance in most cases. Pathogenic variants causing X-linked
KFSD have been described in MBTPS2, the gene for a membrane-bound zinc
metalloprotease that is involved in the cleavage of sterol regulatory element binding
proteins important for the control of transcription. Few families have been identified with
an autosomal dominant inheritance of KFSD. We present two members of an Austrian
family with a phenotype of KFSD, a mother and her son. The disease was not observed
in her parents, pointing to a dominant inheritance with a de novo mutation in the index
patient. Using whole-exome sequencing, we identified a heterozygous missense variant
in CST6 in DNA samples from the index patient and her affected son. In line with family
history, the variant was not present in samples from her parents. CST6 codes for cystatin
M/E, a cysteine protease inhibitor. Patient keratinocytes showed increased expression of
cathepsin genes CTSL and CTSV and reduced expression of transglutaminase genes
TGM1 and TGM3. A relative gain of active, cleaved transglutaminases was found in
patient keratinocytes compared to control cells. The variant found in CST6 is expected
to affect protein targeting and results in marked disruption of the balance between
cystatin M/E activity and its target proteases and eventually transglutaminases 1 and 3.
This disturbance leads to an impairment of terminal epidermal differentiation and proper
hair shaft formation seen in KFSD.
Keywords: keratosis follicularis spinulosa decalvans, congenital disorder of cornification, cicatricial alopecia,
cystatin, transglutaminase, epidermal differentiation, cathepsin
Frontiers in Genetics | www.frontiersin.org 1 July 2021 | Volume 12 | Article 689940
fgene-12-689940 July 5, 2021 Time: 19:33 # 2
Eckl et al. CST6 Variant Causes Autosomal KFSD
INTRODUCTION
Keratosis follicularis spinulosa decalvans (KFSD) is a rare
congenital cornification disorder, characterised by generalised
follicular hyperkeratosis, dry skin, progressive cicatricial alopecia
mainly on the scalp, facial erythema, folliculitis, and eye
symptoms (Bellet et al., 2008; Aten et al., 2010). The majority
of KFSD cases follows an X-linked inheritance pattern (KFSDX,
MIM 308800), however, genetic heterogeneity of KFSD has been
described. Male-to-male transition and a number of pedigrees
with supposed autosomal dominant inheritance have been
identified (MIM 612843) (Oosterwijk et al., 1997; Bellet et al.,
2008; Castori et al., 2009).
Cases of KFSDX are associated with pathogenic variants
in MBTPS2 located on Xp22.12 (Aten et al., 2010). MBTPS2
encodes a membrane bound transcription factor protease, also
known as site-2 protease (S2P). This zinc metalloprotease cleaves
sterol regulatory element-binding proteins (SREBPs), which act
as transcription factors regulating several genes involved in
the cholesterol metabolism. Interestingly, pathogenic variants in
MBTPS2 were also identified in patients with IFAP syndrome
(MIM 308205), a rare genodermatosis characterised by ichthyosis
follicularis, atrichia, and photophobia (Oeffner et al., 2009;
Mégarbané and Mégarbané, 2011).
In a female patient with KFSD and her affected son, we have
now identified a pathogenic variant in CST6 on chromosome
11q13, the gene encoding cystatin M/E. Cystatins act as cystein
protease inhibitors, especially as inhibitors of cathepsins. They
consist of three families and cystatin M/E is a type 2 cystatin that
is involved in the regulation of epidermal barrier function and
differentiation of epidermal keratinocytes (Zeeuwen et al., 2001).
Activities of cystatin M/E are mediated by cathepsins D, L, and
V and legumain, which are then involved in the regulation of
activities of transglutaminases 1 and 3. Transglutaminases can
cross-link proteins and are crucially involved in the formation
of cornified cell envelopes in the epidermal stratum corneum
(Zeeuwen et al., 2004, 2010; Brocklehurst and Philpott, 2013).
None of the parents of the affected mother showed any signs of
KFSD and the variant in CST6 was not found in their samples,
indicating autosomal dominant inheritance with a causative de
novo variant in the index patient.
PATIENTS AND METHODS
Probands
Permission for the project was received from the Ethics
Committees of the Medical University of Innsbruck, Austria
(UN4501), the University Research Ethics Sub-Committee at
Edge Hill University (URESC16-KE1), and the School Research
Ethics and Integrity Committee at the University of Huddersfield
(SAS-SREIC 4.1.19-13). Samples were collected after written
informed consent had been granted. The adult female index
patient (IK-II/1) provided EDTA blood, scalp hair with roots
and a skin punch biopsy. Both parents (IK-I/1 and IK-
I/2) of patient IK-II/1 and her sons (IK-III/1 and IK-III/2)
provided EDTA blood.
DNA Extraction and Sequencing
DNA was extracted from blood samples with standard methods.
For exome sequencing, 3 µg of DNA was fragmented using
sonication technology (Diagenode, Seraing, Belgium). The
fragments were end-repaired and adaptor-ligated. After size
selection, the library was subjected to enrichment using the
Nimblegen SeqCap EZ Human Exome Library v2.0 (Roche,
Madison, WI, United States) enrichment kit and sequenced using
the Illumina HiSeq 2500 instrument (Illumina, San Diego, CA,
United States). Data analysis of filter-passed reads was done
with BWA-short in combination with GATK and SAMTOOLS as
implemented in Varbank (Cologne Center for Genomics). Scripts
were applied for filtering against dbSNP, the 1000 Genomes
Project and an in-house database of exome variants. Search for
genotypes incompatible with Mendelian inheritance was done
using DeNovoGear (Ramu et al., 2013). Further criteria for
variant selection were coverage of more than six reads, minimal
quality score of 10, minor allele frequency <1%. For Sanger
sequencing, exons were PCR amplified and products directly
sequenced using the BigDye Terminator v.1.1 Cycle Sequencing
Kit (Applied Biosystems, Foster City, CA, United States) on a
3730 DNA Analyzer (Applied Biosystems).
Isolation of Primary Skin Cells
Keratinocytes and fibroblasts were isolated from the index
patient’s skin punch biopsy sample or plastic surgery surplus skin
samples as described previously (Eckl et al., 2011). Keratinocytes
were cultured in medium KCM (Leigh and Watt, 1994) on a 3T3
feeder cell layer; fibroblasts were grown in DMEM containing
10% FCS and supplemented with 2 mM glutamine, 100 IU/ml
penicillin, and 100 µg/ml streptomycin (all Gibco, Thermo
Fisher Scientific, Vienna, Austria). Gene expression studies, ICC
and Western blotting were obtained from freezing feeder-based
normal human epidermal keratinocytes (NHEK) and re-plating
cells in a defined serum-free medium (KGM, Lonza, Basel,
Switzerland) in the absence of feeder cells 24 to 48 h later.
Additional skin samples from the patient or her affected son for
further experiments were not available.
In vitro Differentiation of Keratinocytes
Patient and control keratinocytes were plated at 4,000 cells per
cm2 in KGM (Lonza, Basel, Switzerland) in the absence of feeder
cells and incubated at 37◦C, 95% humidity, 5% CO2 until 90%
confluent (5 days). To induce terminal epidermal differentiation,
cells were grown with KGM supplemented with 1.15 µl/ml of
a 1M CaCl2 solution. Cells were harvested and pelleted at days
3, 6, and 9. All experiments were conducted in biological and
technical triplicates.
Quantitative PCR
RNA was extracted from feeder-free keratinocyte cultures
(RNeasy Midi Kit, Qiagen, Hilden, Germany) including DNase
digestion as described by the manufacturer. After normalisation
to 1,000 ng/µl, cDNA was synthesised using the High-
Capacity RNA-to-cDNATM Kit (Thermo Fisher Scientific,
Vienna, Austria) following the manufacturer’s instructions with
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1 µg RNA per reaction. Produced cDNA was used in the
following qPCR reactions using pre-designed Taqman probes
(Supplementary Table 1) and the Fast Universal PCR Master Mix
(Thermo Fisher Scientific, Vienna, Austria) on a QuantStudio
5 Real-Time PCR system (Thermo Fisher Scientific, Vienna,
Austria) using 1 µl of a 1:20 dilution of the cDNA for each
reaction in a total volume of 10 µl. Data were analysed using the
11Ct method (Schmittgen and Livak, 2008) with GAPDH, 18S
RNA and HPRT1 as housekeeping genes for normalisation.
Western Blotting
Cell pellets were resuspended in RIPA buffer (Sigma Aldrich,
Munich, German) supplemented with proteinase inhibitor
cocktail (final concentration 1:100, Sigma Aldrich, Munich,
Germany). Cells were thoroughly vortexed at high speed and
subjected to several freeze-thaw cycles at −20◦C before samples
were centrifuged at 4◦C for 10 min at 8,000×g. The supernatant
containing the protein fraction was transferred to fresh tubes,
aliquotted and stored at −80◦C for later use for standard
protocols for SDS page Western blotting with antibodies listed
in Supplementary Table 2.
Immunocytochemistry
Keratinocytes from patient IK-II/1 and a matched control donor
were cultured on poly-L-lysine coated glass coverslips, fixed
with ice-cold methanol and stored at −20◦C until further use.
Cells were washed once with DPBS, permeabilised with PBS
containing 1% Triton X-100 in 1% BSA for 10 min at RT followed
by 2 h blocking with 10% FCS/3% BSA/DPBS at RT (FCS,
DPBS w/o Mg2+, Ca2+ from Gibco, Thermo Fisher Scientific;
BSA from Carl Roth, Karlsruhe, Germany; Triton X-100 from
Sigma Aldrich). Primary antibodies were applied over night at
4◦C followed by washing steps with DBPS containing 1% BSA.
After incubation with fluorescence-labelled secondary antibodies
in the dark for 2 h at RT, cells were washed once, nuclear
counterstain (DAPI, Sigma Aldrich) was incubated for 5 min,
followed by washing steps with DPBS/BSA, DPBS, and distilled
water. Cells on coverslips were mounted on slides using a water-
soluble mounting medium (Fluoromount Mounting Medium,
Sigma Aldrich). Results were visualised on a DMi8 fluorescence
microscope (Leica, Wetzlar, Germany). Antibodies and dilutions
are listed in Supplementary Table 2.
Immunohistochemistry
A quarter of the index patient’s skin biopsy was paraffin
embedded and used for standard IHC/P analysis with primary
and secondary antibodies listed in Supplementary Table 2.
A second quarter of the skin biopsy was snap frozen and used
for IHC/F, antibodies listed in Supplementary Table 2.
Statistical Analysis
One-way analysis of variance (ANOVA) with Tukey’s correction
for multiple comparisons, or Dunnet’s correction for multiple
comparisons against a single control, were used to assess
statistically significant differences within data sets (GraphPad
Prism v8, GraphPad Software Inc., La Jolla, CA, United States),
and p values were determined using Student’s t-test.
RESULTS
Patients With Keratosis Follicularis
Spinulosa Decalvans
The index patient (IK-II/2) of an Austrian family with KFSD
(Figure 1A), a 31-year-old woman, presented with generalised
follicular hyperkeratosis, dry skin, scarring alopecia on the
scalp, sparse eyebrows and eyelashes and occipital folliculitis
(Figure 1B). In addition, she showed hypohidrosis and myopia
with astigmatism. Her 4-year-old son (IK-III/1) exhibited severe
cradle cap postnatally and a bacterial conjunctivitis, but later he
developed a skin phenotype like his mother, with sparse hair
and lack of eyelashes. His cicatricial alopecia was limited to
the parietal scalp (Figures 1B/v,vi). Mother and son reported
pruritus in particular in areas of cicatricial alopecia. The other
family members did not exhibit any cutaneous symptoms.
A medical check-up of both affected individuals did not reveal
signs of physical or intellectual disabilities or an involvement of
other organs. H&E staining of the paraffin-embedded skin sample
of the index patient showed acanthosis with elongated rete ridges
and perifollicular fibrosis (Figure 1C/i).
Mutation Analysis
After variants in MBTPS2 had been ruled out as a cause for
the disease by direct sequencing, DNA samples from the index
patient and her parents were further analysed by whole-exome
sequencing. The sequencing achieved a mean coverage of 92×,
103×, and 122×, respectively, with 10× coverage of at least 97%
of the targets. Taking co-segregation into consideration, missense
variants in three genes were identified (CST6, EMSY, and PHB).
Focusing on prominent gene expression in keratinocytes and
hair follicles (Fagerberg et al., 2014; Uhlén et al., 2015), only
one variant was identified, c.65T > C in CST6 (NM_001323.4;
Genbank gene ID 1474). The variant is predicted to lead
to the replacement of leucine by proline at residue 22 of
cystatin M/E [p.(Leu22Pro)]. The affected residue Leu22 is
highly conserved, showing 70% identity in an alignment of
cystatin M/E orthologs with HMMER 3 in 150 species and
86% in an iterated psi-BLAST alignment (111 species). The
physicochemical difference is moderate between Leu and Pro
(Grantham score 98), however, SIFT and PolyPhen predicted
the variant as deleterious (SIFT score 0) and probably damaging
(PolyPhen-2 score 0.927), respectively. The variant has not been
identified in sequencing projects (gnomAD, 1000 genomes).
Sanger sequencing in samples from the index patient, her parents
(IK-I/1, 2) and sons (IK-III/1, 2) showed absence of this variant in
the parents, confirming de novo occurrence, and co-segregation
with the phenotype in the sons (Supplementary Figure 1).
Gene Expression Analysis
CST6 encodes cystatin M/E, which antagonises lysosomal
cysteine proteases. IHC/P analysis of patient skin samples showed
a broadened expression of cystatin M/E (Figures 1C/ii–iv).
Quantitative analysis of CST6 transcripts in patient keratinocytes
cultured under feeder-free, high Ca2+ (1.15 mM) conditions
showed a slight reduction as compared to control samples
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FIGURE 1 | (A) Pedigree showing the index patient II/2 and her affected son III/1. The parents of the index patient and her second son were skin-healthy. (B) (i)
Generalised follicular hyperkeratosis and xerosis in the index patient. (ii) Scarring alopecia and folliculitis on the scalp, sparse eyebrows and eyelashes in the index
patient. (iii) Marked occipital folliculitis in the index patient. (iv) Generalised follicular hyperkeratosis in the index patient’s first son (IK-III/1). (v) Cicatricial alopecia on
the parietal scalp in patient IK-III/1. (vi) Severe cradle cap and sparse eyebrows in patient IK-III/1 at the age of 2 weeks. (C) (i) H&E staining of paraffin sections of the
index patient skin sample showing mild hyperkeratosis, acanthosis with elongated rete ridges and perifollicular fibrosis. (ii–iv) Cystatin M/E expression in
paraffin-embedded skin samples from patient IK-II/1 (ii,iii) and healthy control person (iv). Cystatin M/E expression is confined to the upper layers of the viable
epidermis in control samples but distributed over all suprabasal layers in the patient sample. (ii,iv) Merged images with DAPI staining, (iii) cystatin M/E staining only.
Magnification bar represents 25 µm.
(Figure 2). We investigated the expression of cathepsins
directly regulated by cystatin M/E in terminally differentiating
keratinocytes. We found a significant increase in expression
of CTSL and CTSV in patient cells as compared to matched
controls (Figure 2A); in contrast, there was no significant change
in LGMN expression (not shown). We did not detect any
differences in the distribution of transglutaminase 1 (Tgase-1)
in paraffin-embedded skin sections from the patient specimen
(Supplementary Figure 2); however, TGM1 expression was
strongly reduced in patient cells compared to healthy controls
(Figure 2A). Importantly, TGM3 expression was also markedly
reduced in patient keratinocytes (Figure 2A).
To follow up on these findings, we investigated Tgase-1 and
Tgase-3 by Western blot analysis. Tgase-1 was weak in patient
samples after 3 and 6 days of differentiation but strong on
day 9 with a prominent 33 kDa band, indicating the smaller
cytosolic fragment and showing an increased fractionising and
activation of Tgase-1 in patient cells (Figure 2B). Full-length
Tgase-3 was present at day 3 of differentiation but not detectable
in day 6 or day 9 patient samples, suggesting either a lack of
Tgase-3 at days 6 and 9 or, more probably, a nearly complete
digestion of the 77 kDa zymogen to its active 33/47 kDa
fragments, which were not detectable with this analysis. Variants
in other protease inhibitors have been described to cause cell-cell
adhesion deficits (Blaydon et al., 2011). Therefore, we assessed
the distribution of E-cadherin in patient cells (Figure 3) and
investigated co-localisations of cystatin M/E with GM130 and
keratin 14, respectively (Figures 3/ii,iii). These experiments
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FIGURE 2 | (A) Analysis of relative expression for genes CST6, TGM1, TGM3, CTSL, CTSV, TP63, FBL, and SATB1 comparing RNA from patient and control
keratinocytes grown feeder-free under high Ca2+ conditions and normalised to 18S RNA and housekeeping genes GAPDH and HPRT1. All gene expression studies
were conducted in biological triplicates. Expression of TGM1 and TGM3 was significantly reduced in patient keratinocytes. Expression of cathepsin genes was
strongly upregulated. ns, not significant; ∗p ≤ 0.05; ∗∗p ≤ 0.01; ∗∗∗p ≤ 0.001. (B) Western blotting analysis of (i) Tgase-1 and (ii) Tgase-3 in patient (P) and matched
control (C) keratinocytes. Keratinocytes were cultured for 3, 6, and 9 days under high Ca2+ conditions. β-actin was used as a loading control. (i) Tgase-1 was only
weakly expressed in day 3 and day 6 patient cells but stronger after 9 days, with a prominent 33 kDa band indicating an increased fractionising of Tgase-1 in patient
cells. (ii) Full-length Tgase-3 was not detectable in day 6 or day 9 patient samples, suggesting either a lack of Tgase-3 or a near-to-complete fractionising of the
77 kDa zymogen to its active 33/47 kDa fragments, which were not detectable with this analysis.
showed a strong presence of cystatin M/E in the cytoplasm
but no signs of disturbed keratinocyte adhesion or cytoskeleton.
Additional qPCR analysis for TP63 and SATB1, which are
involved in tissue-specific chromatin remodelling and the control
of epidermal differentiation, showed an upregulation in patient
cells (Figure 2A).
DISCUSSION
Cystatin M/E is a type II cystatin that is both glycosylated
and phosphorylated and secreted into the extracellular space.
It is synthesised as a pre-protein with an N-terminal signal
sequence. While the extent of the signal peptide is not completely
clear (Ni et al., 1997; Sotiropoulou et al., 1997), hydrophobicity
analysis pointed to a 22-residue signal peptide. This is underlined
by the fact that cystatin M/E has a proline residue at position
23 and several arginine as well as other charged residues
immediately thereafter. This means that alterations at Leu22, the
residue affected here, would most probably affect the processing
of the pre-protein and thus the targeting of active cystatin
M/E. Preliminary experiments indicated a marked location of
mutated cystatin M/E in the cytosol. Similarly, a substitution
of alanine by threonine at position 25 in cystatin C, the last
of the N-terminal hydrophobic residues, was associated with
an increased susceptibility to age-related macular degeneration
(Zurdel et al., 2002). Recombinant altered cystatin C was
erroneously targeted to mitochondria and also found throughout
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FIGURE 3 | Patient keratinocytes were grown on coverslips and double-stained with antibodies against cystatin M/E (red) and (i) E-cadherin, (ii) GM130, or (iii)
keratin 14 (green). Counterstaining was done with DAPI. Patient keratinocytes clearly expressed cystatin M/E abundantly in the cytosol. For the keratin 14
double-staining, DAPI (blue), keratin 14 (green), and cystatin M/E (red) are shown separately and merged. Magnification bars represent 25 µm (i) or 50 µm (ii,iii).
the cytoplasm and nucleus of retinal cells (Paraoan et al., 2004);
secretion of a threonine variant fusion protein was reduced by
approximately 50% compared with wild-type protein.
Cystatin M/E inhibits legumain and cathepsins L and V
(Zeeuwen et al., 2007) and acts as a tumour suppressor (Briggs
et al., 2010). Cathepsins are cysteine proteases essential for
proper cornification and hair shaft development and required
for the activation and processing of a variety of epidermal
proteins, amongst them Tgase-1 and Tgase-3 (Cheng et al.,
2009; Zeeuwen et al., 2010). Increased expression of CTSV
and CTSL might indicate a feedback regulation following the
cytosolic activity of mutant inhibitor cystatin M/E. Dysregulation
of Tgase 1 and Tgase 3 can account for disturbed terminal
differentiation of keratinocytes, hyperkeratosis and hair shaft
anomalies (Candi et al., 2005; Eckhart et al., 2013). SATB1 and
p63, transcription and remodelling factors encoded by SATB1
and TP63, may contribute to the phenotype of hyperplasia
and hyperkeratosis.
Recently, Van den Bogaard and colleagues described a family
with autosomal recessive hypotrichosis and dry skin caused by
homozygous nonsense variant c.361C > T in CST6, resulting in
the expression of truncated and only partly functional cystatin
M/E that lacked the inhibitory function for cathepsins V and
L and legumain (van den Bogaard et al., 2019). Heterozygous
family members did not show any related symptoms. In
contrast, the heterozygous variant described here is expected
to result in a gain of function. Whereas patients in the above
family presented with hypotrichosis of scalp and body hair, the
patients presented here with autosomal dominant KFSD due to
a CST6 variant display follicular hyperkeratosis and scarring.
Individuals from both families showed sparse eyelashes and
hypohidrosis. These phenotypic differences indicate alternative
pathomechanisms. Whereas TGM1 expression was increased
in samples from patients with homozygous loss-of-function
variants in CST6, we observed a decline of TGM1 expression
in samples with the dominant CST6 variant. Further studies
will be needed to determine the outcome of the altered
CST6 mutant in more details and to substantiate its effects
on cathepsin expression and activity. A significantly altered
activation pattern of transglutaminases in keratinocytes from our
patients indicates disturbance of cornification associated with
substantially increased cathepsin levels.
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